Menu
Back to User profile » Dr Chung-Mou Kuo
Papers published by Dr Chung-Mou Kuo:
The Clinical Presentations of Liver Abscess Development After Endoscopic Retrograde Cholangiopancreatography with Choledocholithiasis: A 17-Year Follow-Up
Liu AC, Tai WC, Chiu SM, Sou FM, Yang SC, Lu LS, Kuo CM, Chiu YC, Chuah SK, Liang CM, Wu CK
Infection and Drug Resistance 2023, 16:6167-6174
Published Date: 13 September 2023
A Comparison Between Dexlansoprazole Modified Release–Based And Lansoprazole-Based Nonbismuth Quadruple (Concomitant) Therapy For First-Line Helicobacter pylori Eradication: A Prospective Randomized Trial [Corrigendum]
Tai WC, Liang CM, Bi KW, Kuo CM, Lu LS, Wu CK, Yang SC, Kuo YH, Lee CH, Huang CF, Hsu CN, Hsu PI, Wu DC, Hu TH, Wu KL, Chuah SK
Infection and Drug Resistance 2019, 12:3049-3050
Published Date: 25 September 2019
A comparison between dexlansoprazole modified release–based and lansoprazole-based nonbismuth quadruple (concomitant) therapy for first-line Helicobacter pylori eradication: a prospective randomized trial
Tai WC, Liang CM, Bi KW, Kuo CM, Lu LS, Wu CK, Yang SC, Kuo YH, Lee CH, Huang CF, Hsu CN, Hsu PI, Wu DC, Hu TH, Wu KL, Chuah SK
Infection and Drug Resistance 2019, 12:2923-2931
Published Date: 16 September 2019
First-line Helicobacter pylori eradication rates are significantly lower in patients with than those without type 2 diabetes mellitus
Yao CC, Kuo CM, Hsu CN, Yang SC, Wu CK, Tai WC, Liang CM, Wu KL, Huang CF, Bi KW, Lee CH, Chuah SK
Infection and Drug Resistance 2019, 12:1425-1431
Published Date: 29 May 2019